|
1
|
Liang Y, Song X, Li Y, Chen B, Zhao W,
Wang L, Zhang H, Liu Y, Han D, Zhang N, et al: LncRNA BCRT1
promotes breast cancer progression by targeting miR-1303/PTBP3
axis. Mol Cancer. 19:852020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2022. CA Cancer J Clin. 72:7–33. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gao JJ and Swain SM: Luminal A breast
cancer and molecular assays: A review. Oncologist. 23:556–565.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
DeSantis CE, Ma J, Gaudet MM, Newman LA,
Miller KD, Goding Sauer A, Jemal A and Siegel RL: Breast cancer
statistics, 2019. CA Cancer J Clin. 69:438–451. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pan C, Cong A and Ni Q: Microarray data
reveal potential genes that regulate triple-negative breast cancer.
J Int Med Res. 50:30006052211301882022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang M, Zhang L, Geng A, Li X, Zhou Y, Xu
L, Zeng YA, Li J and Cai C: CDK14 inhibition reduces mammary stem
cell activity and suppresses triple negative breast cancer
progression. Cell Rep. 40:1113312022. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lu Z, Mao W, Yang H, Santiago-O'Farrill
JM, Rask PJ, Mondal J, Chen H, Ivan C, Liu X, Liu CG, et al: SIK2
inhibition enhances PARP inhibitor activity synergistically in
ovarian and triple-negative breast cancers. J Clin Invest.
132:e1464712022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Coates JT, Sun S, Leshchiner I, Thimmiah
N, Martin EE, McLoughlin D, Danysh BP, Slowik K, Jacobs RA,
Rhrissorrakrai K, et al: Parallel genomic alterations of antigen
and payload targets mediate polyclonal acquired clinical resistance
to sacituzumab govitecan in triple-negative breast cancer. Cancer
Discov. 11:2436–2445. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Goodman CR, Seagle BL, Friedl TWP, Rack B,
Lato K, Fink V, Cristofanilli M, Donnelly ED, Janni W, Shahabi S
and Strauss JB: Association of circulating tumor cell status with
benefit of radiotherapy and survival in early-stage breast cancer.
JAMA Oncol. 4:e1801632018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Alamilla-Presuel JC, Burgos-Molina AM,
González-Vidal A, Sendra-Portero F and Ruiz-Gómez MJ: Factors and
molecular mechanisms of radiation resistance in cancer cells. Int J
Radiat Biol. 98:1301–1315. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhao W, Sun M, Li S, Chen Z and Geng D:
Transcription factor ATF3 mediates the radioresistance of breast
cancer. J Cell Mol Med. 22:4664–4675. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Troschel FM, Böhly N, Borrmann K, Braun T,
Schwickert A, Kiesel L, Eich HT, Götte M and Greve B: miR-142-3p
attenuates breast cancer stem cell characteristics and decreases
radioresistance in vitro. Tumour Biol. 40:10104283187918872018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Perez-Añorve IX, Gonzalez-De la Rosa CH,
Soto-Reyes E, Beltran-Anaya FO, Del Moral-Hernandez O,
Salgado-Albarran M, Angeles-Zaragoza O, Gonzalez-Barrios JA,
Landero-Huerta DA, Chavez-Saldaña M, et al: New insights into
radioresistance in breast cancer identify a dual function of
miR-122 as a tumor suppressor and oncomiR. Mol Oncol. 13:1249–1267.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Feketea G, Bocsan CI, Popescu C, Gaman M,
Stanciu LA and Zdrenghea MT: A review of macrophage MicroRNAs' role
in human asthma. Cells. 8:422019. View Article : Google Scholar
|
|
15
|
Xue T, Liang W, Li Y, Sun Y, Xiang Y,
Zhang Y, Dai Z, Duo Y, Wu L, Qi K, et al: Ultrasensitive detection
of miRNA with an antimonene-based surface plasmon resonance sensor.
Nat Commun. 10:282019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ni Q, Stevic I, Pan C, Müller V,
Oliveira-Ferrer L, Pantel K and Schwarzenbach H: Different
signatures of miR-16, miR-30b and miR-93 in exosomes from breast
cancer and DCIS patients. Sci Rep. 8:129742018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pan C, Sun G, Sha M, Wang P, Gu Y and Ni
Q: Investigation of miR-93-5p and its effect on the
radiosensitivity of breast cancer. Cell Cycle. 20:1173–1180. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Amin MB, Edge S, Greene F, Byrd DR,
Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR,
Sullivan DC, et al: AJCC cancer staging manual. 8th edition.
Springer International Publishing; New York, NY: 2017, View Article : Google Scholar
|
|
20
|
Tajbakhsh A, Rivandi M, Abedini S, Pasdar
A and Sahebkar A: Regulators and mechanisms of anoikis in
triple-negative breast cancer (TNBC): A review. Crit Rev Oncol
Hematol. 140:17–27. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fultang N, Illendula A, Chen B, Wu C,
Jonnalagadda S, Baird N, Klase Z and Peethambaran B: Strictinin, a
novel ROR1-inhibitor, represses triple negative breast cancer
survival and migration via modulation of PI3K/AKT/GSK3ß activity.
PLoS One. 14:e2177892019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ahmed K, Koval A, Xu J, Bodmer A and
Katanaev VL: Towards the first targeted therapy for triple-negative
breast cancer: Repositioning of clofazimine as a
chemotherapy-compatible selective Wnt pathway inhibitor. Cancer
Lett. 449:45–55. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sun XY, Han XM, Zhao XL, Cheng XM and
Zhang Y: MiR-93-5p promotes cervical cancer progression by
targeting THBS2/MMPS signal pathway. Eur Rev Med Pharmacol Sci.
23:5113–5121. 2019.PubMed/NCBI
|
|
24
|
Wu H, Liu L and Zhu JM: MiR-93-5p
inhibited proliferation and metastasis of glioma cells by targeting
MMP2. Eur Rev Med Pharmacol Sci. 23:9517–9524. 2019.PubMed/NCBI
|
|
25
|
Wang Q, Su C, Li J and Wei C: Mechanism of
the enhancing effects of miR-93 on resistance of breast cancer
MCF-7 cells to adriamycin. Oncol Lett. 16:3779–3783.
2018.PubMed/NCBI
|
|
26
|
Ge YW, Liu ZQ, Sun ZY, Yu DG, Feng K, Zhu
ZA and Mao YQ: Titanium particle-mediated osteoclastogenesis may be
attenuated via bidirectional ephrin-B2/eph-B4 signaling in
vitro. Int J Mol Med. 42:2031–2041. 2018.PubMed/NCBI
|
|
27
|
Chen R, Yang X, Zhang B, Wang S, Bao S, Gu
Y and Li S: EphA4 negatively regulates myelination by inhibiting
schwann cell differentiation in the peripheral nervous system.
Front Neurosci. 13:11912019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pan Y, Lu S, Lei L, Lamberto I and Wang Y,
Pasquale EB and Wang Y: Genetically encoded FRET biosensor for
visualizing EphA4 activity in different compartments of the plasma
membrane. ACS Sens. 4:294–300. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Okyere B, Mills WR, Wang X, Chen M, Chen
J, Hazy A, Qian Y, Matson JB and Theus MH: EphA4/Tie2 crosstalk
regulates leptomeningeal collateral remodeling following ischemic
stroke. J Clin Invest. 130:1024–1035. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen X, Yang H, Zhou X, Zhang L and Lu X:
MiR-93 targeting EphA4 promotes neurite outgrowth from spinal cord
neurons. J Mol Neurosci. 58:517–524. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kina S, Kinjo T, Liang F, Nakasone T,
Yamamoto H and Arasaki A: Targeting EphA4 abrogates intrinsic
resistance to chemotherapy in well-differentiated cervical cancer
cell line. Eur J Pharmacol. 840:70–78. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
de Marcondes PG and Morgado-Diaz JA: The
role of EphA4 signaling in radiation-induced EMT-like phenotype in
colorectal cancer cells. J Cell Biochem. 118:442–445. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
de Marcondes PG, Bastos LG,
De-Freitas-Junior JC, Rocha MR and Morgado-Díaz JA: EphA4-mediated
signaling regulates the aggressive phenotype of irradiation
survivor colorectal cancer cells. Tumour Biol. 37:12411–12422.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sun Y, Qian J, Lu M and Xu H: Lower and
reduced expression of EphA4 is associated with advanced TNM stage,
lymph node metastasis, and poor survival in breast carcinoma.
Pathol Int. 66:506–510. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dong Y, Liu Y, Jiang A, Li R, Yin M and
Wang Y: MicroRNA-335 suppresses the proliferation, migration, and
invasion of breast cancer cells by targeting EphA4. Mol Cell
Biochem. 439:95–104. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zheng J, Wang B, Zheng R, Zhang J, Huang
C, Zheng R, Huang Z, Qiu W, Liu M, Yang K, et al: Linc-RA1 inhibits
autophagy and promotes radioresistance by preventing H2Bub1/USP44
combination in glioma cells. Cell Death Dis. 11:7582020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sen R and Baltimore D: Multiple nuclear
factors interact with the immunoglobulin enhancer sequences. Cell.
1986.46:705–716. J Immunol. 177:7485–7496. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hou Y, Liang H, Rao E, Zheng W, Huang X,
Deng L, Zhang Y, Yu X, Xu M, Mauceri H, et al: Non-canonical NF-κB
antagonizes STING sensor-mediated DNA sensing in radiotherapy.
Immunity. 49:490–503.e4. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lu H, Clauser KR, Tam WL, Fröse J, Ye X,
Eaton EN, Reinhardt F, Donnenberg VS, Bhargava R, Carr SA and
Weinberg RA: A breast cancer stem cell niche supported by
juxtacrine signalling from monocytes and macrophages. Nat Cell
Biol. 16:1105–1117. 2014. View Article : Google Scholar : PubMed/NCBI
|
